tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Hoth Therapeutics Regains Nasdaq Compliance on June 18
PremiumCompany AnnouncementsHoth Therapeutics Regains Nasdaq Compliance on June 18
28d ago
Hoth Therapeutics reports results from multi-dose study of HT-KIT
Premium
The Fly
Hoth Therapeutics reports results from multi-dose study of HT-KIT
1M ago
Hoth Therapeutics granted Japanese patent for HT-KIT platform
Premium
The Fly
Hoth Therapeutics granted Japanese patent for HT-KIT platform
1M ago
Hoth Therapeutics granted Japanese patent for novel RNA-based cancer therapy
PremiumThe FlyHoth Therapeutics granted Japanese patent for novel RNA-based cancer therapy
3M ago
Hoth Therapeutics Reports Positive Phase 2a Trial Results
Premium
Company Announcements
Hoth Therapeutics Reports Positive Phase 2a Trial Results
3M ago
Hoth Therapeutics’ HT-001 shows efficacy in Phase 2a pruritus trial
Premium
The Fly
Hoth Therapeutics’ HT-001 shows efficacy in Phase 2a pruritus trial
3M ago
Hoth Therapeutics announces new patent claim and begins GLP-compliant study
PremiumThe FlyHoth Therapeutics announces new patent claim and begins GLP-compliant study
4M ago
Hoth Therapeutics announces ‘positive’ results from study of HT-KIT
Premium
The Fly
Hoth Therapeutics announces ‘positive’ results from study of HT-KIT
4M ago
Hoth Therapeutics to submit Expanded Access application for HT-001
Premium
The Fly
Hoth Therapeutics to submit Expanded Access application for HT-001
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100